Fifth Annual Clinical Fellowship Competition from NMD4C and MDC Opens May 1st
Together, NMD4C and MDC are excited to open our 2026 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)! This annual funding competition provides one-year salary support ($80, 000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.
This year, the competition dates have been modified to better align with the academic calendar of Canadian residency and fellowship training programs – please note the new spring dates for the clinical fellowship funding competition!
Dates and Timelines
Funding competition opens: May 1, 2025
Application submission deadline: June 12th, 2025
Notification of Funding: July-August 2025
Funds available: July-September 2026
Competition Guidelines
The 2026 competition guidelines are available on the NMD4C website, as well as information on how to submit an application.
Clinical fellowship competition guidelines
If you have any questions about the 2026 competition, please contact network manager Erin Beattie at .
Postdoctoral Research Fellowship Competition to Launch Fall 2025
NMD4C and MDC also hold postdoctoral fellowship awards in neuromuscular disease research as a part of our annual fellowship funding competition. These awards provide salary support for early-career scientists to conduct postdoctoral studies in a Canadian laboratory focused on NMD research. The postdoctoral fellowship competition will continue to take place in the fall. More information on how to apply for this year’s competition will be available in the fall of 2025.
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.